VALIANT LABORATORIES
Back to Cashflow Statement
|
VALIANT LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Cash Flow from Financing Activities | ₹45 Cr | ₹152 Cr | ₹-0.93 Cr |
What is the latest Cash Flow from Financing Activities ratio of VALIANT LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹152 Cr |
| Mar2023 | ₹-0.93 Cr |
How is Cash Flow from Financing Activities of VALIANT LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | -70.71 | |
| Mar2024 | ₹152 Cr | Positive | |
| Mar2023 | ₹-0.93 Cr | - | |
Compare Cash Flow from Financing Activities of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹429.5 Cr | 21.5% | 25.6% | -19.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | 21.5% |
25.6% |
-19.9% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses